during the quickly evolving discipline of cancer therapeutics, comprehension the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is crucial for producing productive therapies. The most promising strategies is the use of in vitro bystander impact assays, which play a pivotal purpose in maximizing therapeutic efficacy. These assays, supplied